Health Powder Inc.

You are here: HomeProductsColuracetam powder

Contact us

  • Company Name: Health Powder Inc.
  • Country/region: China
  • Contact Person: Ms.David Lu
  • Tel: 86-27-86535669
  • Email:

Coluracetam powder

  • CAS No:135463-81-9 N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,<br />3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide
    Molecular Structure

    Detailed Description

    Product Name Coluracetam
    CAS No. 135463-81-9
    Formula C19H23N3O3
    Appearance White powder
    Purity 99.5%
    Package 1Kg/bag
    Description Coluracetam (BCI-540) is a nootropic drug of the racetam family.Coluracetam (formerly known as MKC-231) was initially developed and tested by the Mitsubishi Tanabe Pharma Corporation for Alzheimer's disease. After the drug failed to reach endpoints in its clinical trials it was in-licensed by BrainCells Inc for investigations into major depression disorder (MDD), after being awarded a "Qualifying Therapeutic Discovery Program Grant" by the state of California.Findings from its Phase 2a clinical trials have suggested that it would be an ideal medication for co-morbid MDD with generalized anxiety disorder (GAD).BrainCells Inc is currently out-licensing the drug for this purpose.It may also have potential use in prevention and treatment of ischemic retinopathy and retinal and optic nerve injury.
    Coluracetam enhances high-affinity choline uptake (HACU) which is the rate-limiting step of acetylcholine (ACh) synthesis, and is the only known choline uptake enhancer to currently exist. Studies have shown Coluracetam to improve learning impairment on a single oral dose given to rats which have been exposed to cholinergic neurotoxins. Subsequent studies have shown that it may induce long-lasting procognitive effects by changing the choline transporter regulation system.
  • Coluracetam powder
  • Coluracetam powder